Cáncer y ETV

Evolución de la ETV en pacientes con cáncer

. Monreal M, Falgá C, Vilaseca B, Suárez C, Gabriel F, Tolosa C, Montes J for the RIETE investigators.Clinical outcomes in cancer patients with concurrent venous thromboembolism: findings from the RIETE Registry. Haematologica Reports 2005 Oct; 1(9): 64-65.

 

Muerte por EP o por hemorragia en el cáncer

. Monreal M, Falgá C, Valdés M, Suárez C, Gabriel F, Tolosa C, Montes J for the RIETE Investigators. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE Registry. J Thromb Haemost 2006 Sep; 4(9):1950-6.

 

TVP de extremidad superior en el cáncer

. Monreal M, Muñoz FJ, Rosa V, Romero C, Román P, Di Micco P, Prandoni P. Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE Registry. Exp Oncol 2006 Sep; 28(3): 245-7.

 

Neoplasia oculta en los pacientes con ETV

. Trujillo-Santos J, Prandoni P, Rivron-Guillot K, Román P, Sánchez R, Tiberio G, Monreal M and the RIETE Investigators. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008 Feb; 6(2): 251-55.

 

Predicción de rceidivas y de sangrado en los pacientes con cáncer

. Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M for the RIETE Investigators. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008 Sep; 100(3): 435-9.

 

Influencia de la leucocitosis en el pronóstico

. Trujillo-Santos J, Di Micco P, Iannuzzo M, Lecumberri R, Guijarro R, Madridano O, Monreal M for the RIETE Investigators. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008 Nov; 100(5): 905-11.

 

Predicción de recidivas y sangrado en las mujeres con cáncer

. Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, García-Bragado F, Todolí JA, Monreal M, for the RIETE Investigators. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry. Thromb Res 2009; 123 Suppl 2: S10-5.

 

Prevención de la ETV en pacientes con cáncer en España

. Trujillo-Santos J, Fernández-Capitán C, Rosa V, Gutiérrez MR, Oribe M, Mahe I, Monreal M and the RIETE Investigators. Prevention of venous thromboembolism in patients with cancer in Spain. J Coagul Disord 2011 Oct; 3(1): 64-68.

 

Tratamiento a largo plazo con HBPM de la ETV en pacientes con cáncer

. Marchena PJ, Nieto JA, Guil M, García-Bragado F, Rabuñal R, Boccalon H, Trujillo-Santos J, Monreal M and the RIETE Investigators. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism. Thromb Haemost 2012 Jan; 107(1): 37-43.

 

Identificación del paciente con cáncer y EP que no precisa ingreso hospitalario

. Exter PL, Gómez V, Jiménez D, Trujillo-Santos J, Muriel A, Huisman MV, Monreal M; for the RIETE investigators. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. Chest 2013 Jan; 143(1): 138-145.

 

Predictores de muerte en pacientes con cáncer y ETV

. Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M; for the RIETE Investigators. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE Registry.Thromb Res 2013 Jan; 131(1): 24-30.

 

La ETV en pacientes con cáncer e insuficiencia renal

. Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, Del Toro J, Sahuquillo JC, Pedrajas JM and Huisman MV. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment. J Thromb Haemost 2013 Nov; 11(11): 1968-76.

 

Muerte por hemorragia y por EP en el tratamiento de la ETV en pacientes con cáncer

. Farge-Bancel D, Trujillo-Santos J, Debourdeau P, Bura-Riviere A, Rodriguez-Beltrán EM, Nieto JA, Peris ML, Zeltser D, Mazzolai L, Hij A, Monreal M and the RIETE Investigators. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism. Medicine (Baltimore) 2015 Aug; 94(32): e1235.

 

La ETV en pacientes con glioblastoma multiforme

. Portillo J, de la Rocha IV, Font L, Braester A, Madridano O, Peromingo JA, Apollonio A, Pagán B, Bascuñana J, Monreal M and the RIETE Investigations. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE Registry. Thromb Res 2015 Dec; 136(6): 1199-203.

 

Lecciones de RIETE en pacientes con cáncer y ETV

. Monreal M, Prandoni P, Di Micco P, Barba R, Trujillo-Santos J, Rivron-Guillot K, Decousus H. Lessons learned from Cancer/VTE Registries: Report from RIETE. Thromb Res 2007; 120 (2): S62-S63.

 

Recidivas y sangrados en loa pacientes con cáncer sólido y ETV

. Prandoni P, Trujillo-Santos J, Surico T, Dalla Valle F, Piccioli A, Monreal M for the RIETE Investigators. Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE Registry. Haematologica 2008 Sep; 93(9):1432-4.

 

Hemorragias en el tratamiento de la ETV en pacientes con cáncer

. . Trujillo-Santos J, Nieto J A, Ruiz-Gamietea A, López-Jiménez L, García-Bragado F, Quintavalla R, Monreal M for the RIETE Investigators. Bleeding Complications associated with anticoagulant therapy in patients with cancer. Thromb Res 2010 Apr; 125 Suppl 2:S58-61.

 

Mortalidad a 30 días en mujeres con cáncer y ETV

. Trujillo-Santos J, Casas JM, Casado I, Samperiz AL, Quintavalla R, Sahuquillo JC, Monreal M, and the RIETE Investigators. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry. Thromb Res 2011 Feb;127 Suppl 3:S1-4.

 

EP no sospechada en pacientes con cáncer

. Soler S, Delgado C, Ballaz A, Cisneros E, Malý R, Babalis D, Monreal M and the RIETE Investigators. Unsuspected pulmonary embolism in patients with cancer. Thromb Res 2012 Apr; 129 Suppl 1: S16-9.

 

Inmovilización o cirugía reciente en los pacientes con cáncer y ETV

. Trujillo-Santos J, Gussoni G, Gadelha T, Sánchez Muñoz-Torrero JF, Barrón M, López L, Ruiz-Ruiz J, Fernández-Capitán C, Lorente M, Monreal and the RIETE investigators. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism. Thromb Res 2014 May; 133 Suppl 2: S29-34.

 

Diferencias de género en los pacientes con cáncer y ETV

. Martín-Martos F, Trujillo-Santos J, Barrón M, Vela J, Marchena PJ, Braester A, Hij A, Hernández-Blasco L, Verhamme P, Monreal M and RIETE investigators. Gender differences in cancer patients with acute venous thromboembolism. Thromb Res 2015 Feb; 135 Suppl 1: S12-5.

 

Coagulación intravascular diseminada en los pacientes con càncer y ETV

. Spiezia L, Campello E, Trujillo-Santos J, Piovella C, Brenner B, Monreal M, Prandoni P and the RIETE Investigators. The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism. Blood Coagul Fibrinolysis 2015 Sep; 26(6): 709-11.

Share This